AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors
COSTA MESA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today announced the appointment of Dr. Lester J. Kaplan, PhD to its board of directors.
- COSTA MESA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today announced the appointment of Dr. Lester J. Kaplan, PhD to its board of directors.
- Dr. Kaplan served as the Executive Vice President and President, Research & Development and Global Botox, and a board member of Allergan.
- “I am honored and excited to welcome Dr. Kaplan to the board of directors.
- Dr. Kaplan’s long history of leadership and deep experience in drug development will be invaluable to AiViva BioPharma,” said Diane Tang-Liu, PhD, President and CEO of AiViva.